EXPERIENCE in the MANAGEMENT of PATIENTS with ARTERIAL and VENOUS THROMBOSIS and COVID-19.

ABSTRACT

COVID-19 is represented by a large number of different phenotypes, ranging from asymptomatic infection to the development of severe multiple organ dysfunction syndrome. The mechanisms of development of multiple organ dysfunction syndrome are multifactorial, they frequently include hypercoagulable states and Background thrombus formation. Such mechanisms are diagnosed as thrombotic complications that cause blood clots in veins, pulmonary arteries, and coronary arteries. An observational study revealed that the incidence of venous and arterial thrombosis is as high as 31% in patients with COVID-19 pneumonia. However, large studies regarding this topic have not yet been conducted. To compile and analyze our own observations concerning the clinical course of Aim patients with thrombosis in COVID-19. The study included 5 male patients with arterial and venous thrombosis and Methods COVID-19. The experience in the management of 5 patients with COVID-19 and arterial and venous thrombosis was analyzed. All patients exhibited dynamic changes in their blood coagulation tests. The patients with negative COVID-19 test results on Results admission, and changes in the coagulogram indices found on the day of recurrence of thrombosis were of the most interest. All patients received standard treatment and were discharged upon showing improvement and negative COVID-19 test results. Compiling data on the clinical course of patients with COVID-19 and different Conclusion types of thrombosis allowed us to develop treatment strategy for these groups of patients.Copyright © 2021 Russian Academy of Sciences. All right reserved.